Indications and uses
• temporarily relieves minor aches and pains due to: • headache • minor arthritis pain • muscle aches • colds • temporarily reduces fever
• temporarily relieves minor aches and pains due to: • headache • minor arthritis pain • muscle aches • colds • temporarily reduces fever
do not take more than directed (see overdose warning) adults and children 12 years and over: place 1 powder on tongue every 6 hours, while symptoms persist. Drink a full glass of water with each dose, or stir powder into a glass of water or other liquid. do not take more than 4 powders in 24 hours unless directed by a doctor. children under 12 years of age: ask a doctor.
FAST PAIN RELIEF
Goody’s®
EXTRA STRENGTH
HEADACHE POWDERS
ACETAMINOPHEN • ASPIRIN (NSAID) / CAFFEINE
PAIN RELIEVER / PAIN RELIEVER AID
24 ENVELOPES CONTAINING 6 POWDERS EACH
Drug Facts
(in each powder):
Acetaminophen 260 mg
Aspirin (NSAID*) 520 mg
Caffeine 32.5 mg
*nonsteroidal anti-inflammatory drug
Pain reliever/fever reducer
Pain reliever/fever reducer
Pain reliever aid
• temporarily relieves minor aches and pains due to:
| • headache • minor arthritis pain | • muscle aches • colds |
• temporarily reduces fever
Reye’s syndrome: Children and teenagers who have or are recovering from chicken pox or flu-like symptoms should not use this product. When using this product, if changes in behavior with nausea and vomiting occur, consult a doctor because these symptoms could be an early sign of Reye’s syndrome, a rare but serious illness.
Allergy Alert: Aspirin may cause severe allergic reaction which may include:
• hives • facial swelling • shock • asthma (wheezing).
Liver warning: This product contains acetaminophen. Severe liver damage may occur if you take
Stomach bleeding warning: This product contains a NSAID, which may cause severe stomach
bleeding. The chance is higher if you
taking a prescription drug for diabetes, gout, or arthritis
limit the use of caffeine-containing drugs, food, or drinks because too much caffeine may cause nervousness, irritability, sleeplessness, and, occasionally, rapid heart beat. The recommended dose of this product contains about as much caffeine as a cup of coffee.
ask a health professional before use. It is especially important not to use aspirin during the last 3 months of pregnancy unless definitely directed to do so by a doctor because it may cause problems in the unborn child or complications during delivery.
Taking more than the recommended dose can cause serious health problems. In case of overdose, get medical help or contact a Poison Control Center (1-800-222-1222) right away. Quick medical attention is critical for adults as well as for children even if you do not notice any signs or symptoms.
lactose monohydrate, potassium chloride
1-866-255-5197 (English/Spanish) weekdays
FAST PAIN RELIEF
Goody’s®
EXTRA STRENGTH
HEADACHE POWDERS
ACETAMINOPHEN • ASPIRIN (NSAID) / CAFFEINE
PAIN RELIEVER / PAIN RELIEVER AID
24 ENVELOPES CONTAINING 6 POWDERS EACH
FAST PAIN RELIEF
Goody’s®
EXTRA STRENGTH
HEADACHE POWDERS
ACETAMINOPHEN • ASPIRIN (NSAID) / CAFFEINE
PAIN RELIEVER / PAIN RELIEVER AID
18 Powders
FAST PAIN RELIEF
Goody’s®
EXTRA STRENGTH
HEADACHE POWDERS
ACETAMINOPHEN • ASPIRIN (NSAID) / CAFFEINE
PAIN RELIEVER / PAIN RELIEVER AID
24 Powders
FAST PAIN RELIEF
Goody’s®
EXTRA STRENGTH
HEADACHE POWDERS
ACETAMINOPHEN • ASPIRIN (NSAID) / CAFFEINE
PAIN RELIEVER / PAIN RELIEVER AID
50 Powders
| Class | Version | Type | Effective |
|---|---|---|---|
| ASPIRIN Pharmacologic Class Indexing | 3 | Indexing - Pharmacologic Class | 20191108 |
| CAFFEINE Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 63029-633-01 | Goodys Extra Strength | 24 in 1 BOX | POWDER | 24 | 5 | |
| 63029-644-01 | Goodys Extra Strength | 50 in 1 BOX | POWDER | 50 | 5 | |
| 63029-655-01 | Goodys Extra Strength | 18 in 1 BOX | POWDER | 18 | 5 | |
| 63029-662-01 | Goodys Extra Strength | 6 in 1 BOX | POWDER | 6 | 5 |
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 63029-633 | GOODYS EXTRA STRENGTH (ACETAMINOPHEN, ASPIRIN, AND CAFFEINE) POWDER [MEDTECH PRODUCTS INC.] | 5 | Legacy NDC, 1 package rows | 20241101_16d774cc-4247-4bf8-9b5a-c338ffebda3d.zip |
| 63029-644 | GOODYS EXTRA STRENGTH (ACETAMINOPHEN, ASPIRIN, AND CAFFEINE) POWDER [MEDTECH PRODUCTS INC.] | 5 | Current NDC, Legacy NDC, 1 package rows | 20241101_16d774cc-4247-4bf8-9b5a-c338ffebda3d.zip |
| 63029-655 | GOODYS EXTRA STRENGTH (ACETAMINOPHEN, ASPIRIN, AND CAFFEINE) POWDER [MEDTECH PRODUCTS INC.] | 5 | Legacy NDC, 1 package rows | 20241101_16d774cc-4247-4bf8-9b5a-c338ffebda3d.zip |
| 63029-662 | GOODYS EXTRA STRENGTH (ACETAMINOPHEN, ASPIRIN, AND CAFFEINE) POWDER [MEDTECH PRODUCTS INC.] | 5 | Legacy NDC, 1 package rows | 20241101_16d774cc-4247-4bf8-9b5a-c338ffebda3d.zip |
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 63029-662-01 | EA - Each | 63029-662 | 1a3ff3c5-6244-4643-93f5-cc3c7a772c24 | 1 | 2022-06-06 |
| 63029-633-01 | EA - Each | 63029-633 | ac8d4385-921e-48ee-af59-2ae416a335a1 | 1 | 2022-06-06 |
| 63029-644-01 | EA - Each | 63029-644 | 8dd4b674-8cb1-4a69-a7f6-43e8af8484f9 | 1 | 2022-06-06 |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| ACETAMINOPHEN | ACTIVE INGREDIENT | 362O9ITL9D | 2 | |
| ASPIRIN | ACTIVE INGREDIENT | R16CO5Y76E | 2 | |
| CAFFEINE | ACTIVE INGREDIENT | 3G6A5W338E | 2 | |
| ACETAMINOPHEN | ACTIVE MOIETY | 362O9ITL9D | 2 | |
| ASPIRIN | ACTIVE MOIETY | R16CO5Y76E | 2 | |
| CAFFEINE | ACTIVE MOIETY | 3G6A5W338E | 2 | |
| LACTOSE MONOHYDRATE | INACTIVE INGREDIENT | EWQ57Q8I5X | 2 | |
| POTASSIUM | INACTIVE INGREDIENT | RWP5GA015D | 2 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 63029-662 | 63029-662-01 |
| 63029-655 | 63029-655-01 |
| 63029-633 | 63029-633-01 |
| 63029-644 | 63029-644-01 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| ACETAMINOPHEN | 362O9ITL9D | ACTIB |
| ASPIRIN | R16CO5Y76E | ACTIB |
| CAFFEINE | 3G6A5W338E | ACTIB |
| POTASSIUM | RWP5GA015D | IACT |
| LACTOSE MONOHYDRATE | EWQ57Q8I5X | IACT |
| ACETAMINOPHEN | 362O9ITL9D | ACTIB |
| ASPIRIN | R16CO5Y76E | ACTIB |
| CAFFEINE | 3G6A5W338E | ACTIB |
| POTASSIUM | RWP5GA015D | IACT |
| LACTOSE MONOHYDRATE | EWQ57Q8I5X | IACT |
| ACETAMINOPHEN | 362O9ITL9D | ACTIB |
| ASPIRIN | R16CO5Y76E | ACTIB |
| CAFFEINE | 3G6A5W338E | ACTIB |
| POTASSIUM | RWP5GA015D | IACT |
| LACTOSE MONOHYDRATE | EWQ57Q8I5X | IACT |
| ACETAMINOPHEN | 362O9ITL9D | ACTIB |
| ASPIRIN | R16CO5Y76E | ACTIB |
| CAFFEINE | 3G6A5W338E | ACTIB |
| POTASSIUM | RWP5GA015D | IACT |
| LACTOSE MONOHYDRATE | EWQ57Q8I5X | IACT |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| LACTOSE MONOHYDRATE | LACTOSE MONOHYDRATE | EWQ57Q8I5X | POWDER / ORAL | 50 mg | ||
| LACTOSE MONOHYDRATE | LACTOSE MONOHYDRATE | EWQ57Q8I5X | POWDER / ORAL | 50 mg |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Goodys Extra Strength | ACETAMINOPHEN, ASPIRIN, AND CAFFEINE | Medtech Products Inc. | 16d774cc-4247-4bf8-9b5a-c338ffebda3d | 2024-10-25 | Warnings | 63029-644-01 63029-655-01 63029-662-01 63029-633-01 63029-655 63029-633 63029-644 63029-662 63029065501 63029063301 63029064401 63029066201 fcd02d17-893b-44ea-870f-29d2ae58a9b9 16d774cc-4247-4bf8-9b5a-c338ffebda3d |
Adverse event summaries are temporarily unavailable. Other product information remains available.